TY - JOUR AU - Torre, L. A. AU - Bray, F. AU - Siegel, R. L. AU - Ferlay, J. AU - Lortet-Tieulent, J. AU - Jemal, A. PY - 2015 DA - 2015// TI - Global cancer statistics, 2012 JO - CA Cancer J Clin VL - 65 UR - https://doi.org/10.3322/caac.21262 DO - 10.3322/caac.21262 ID - Torre2015 ER - TY - JOUR AU - Musgrove, E. A. AU - Caldon, C. E. AU - Barraclough, J. AU - Stone, A. AU - Sutherland, R. L. PY - 2011 DA - 2011// TI - Cyclin D as a therapeutic target in cancer JO - Nat Rev Cancer VL - 11 UR - https://doi.org/10.1038/nrc3090 DO - 10.1038/nrc3090 ID - Musgrove2011 ER - TY - JOUR AU - Theegarten, D. AU - Hager, T. PY - 2016 DA - 2016// TI - Pathology of lung cancer JO - Radiologe VL - 56 UR - https://doi.org/10.1007/s00117-016-0154-2 DO - 10.1007/s00117-016-0154-2 ID - Theegarten2016 ER - TY - JOUR AU - Sandler, A. AU - Gray, R. AU - Perry, M. C. AU - Brahmer, J. AU - Schiller, J. H. AU - Dowlati, A. PY - 2006 DA - 2006// TI - Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer JO - N Engl J Med VL - 355 UR - https://doi.org/10.1056/NEJMoa061884 DO - 10.1056/NEJMoa061884 ID - Sandler2006 ER - TY - JOUR AU - Hirsch, F. R. AU - Scagliotti, G. V. AU - Mulshine, J. L. AU - Kwon, R. AU - Curran, W. J. AU - Wu, Y. L. PY - 2017 DA - 2017// TI - Lung cancer: current therapies and new targeted treatments JO - Lancet VL - 389 UR - https://doi.org/10.1016/S0140-6736(16)30958-8 DO - 10.1016/S0140-6736(16)30958-8 ID - Hirsch2017 ER - TY - JOUR AU - Tsao, A. S. AU - Scagliotti, G. V. AU - Bunn, P. A. AU - Carbone, D. P. AU - Warren, G. W. AU - Bai, C. PY - 2016 DA - 2016// TI - Scientific advances in lung cancer 2015 JO - J Thorac Oncol. VL - 11 UR - https://doi.org/10.1016/j.jtho.2016.03.012 DO - 10.1016/j.jtho.2016.03.012 ID - Tsao2016 ER - TY - JOUR AU - Otto, T. AU - Sicinski, P. PY - 2017 DA - 2017// TI - Cell cycle proteins as promising targets in cancer therapy JO - Nat Rev Cancer VL - 17 UR - https://doi.org/10.1038/nrc.2016.138 DO - 10.1038/nrc.2016.138 ID - Otto2017 ER - TY - JOUR AU - Schwartz, G. K. AU - Shah, M. A. PY - 2005 DA - 2005// TI - Targeting the cell cycle: a new approach to cancer therapy JO - J Clin Oncol VL - 23 UR - https://doi.org/10.1200/JCO.2005.01.5594 DO - 10.1200/JCO.2005.01.5594 ID - Schwartz2005 ER - TY - JOUR AU - Hartwell, L. H. AU - Kastan, M. B. PY - 1994 DA - 1994// TI - Cell cycle control and cancer JO - Science VL - 266 UR - https://doi.org/10.1126/science.7997877 DO - 10.1126/science.7997877 ID - Hartwell1994 ER - TY - JOUR AU - Tamakawa, R. A. AU - Fleisig, H. B. AU - Wong, J. M. PY - 2010 DA - 2010// TI - Telomerase inhibition potentiates the effects of genotoxic agents in breast and colorectal cancer cells in a cell cycle-specific manner JO - Cancer Res VL - 70 UR - https://doi.org/10.1158/0008-5472.CAN-10-2227 DO - 10.1158/0008-5472.CAN-10-2227 ID - Tamakawa2010 ER - TY - JOUR AU - Senese, S. AU - Lo, Y. C. AU - Huang, D. AU - Zangle, T. A. AU - Gholkar, A. A. AU - Robert, L. PY - 2014 DA - 2014// TI - Chemical dissection of the cell cycle: probes for cell biology and anti-cancer drug development JO - Cell Death Dis. VL - 5 UR - https://doi.org/10.1038/cddis.2014.420 DO - 10.1038/cddis.2014.420 ID - Senese2014 ER - TY - JOUR AU - Manchado, E. AU - Guillamot, M. AU - Malumbres, M. PY - 2012 DA - 2012// TI - Killing cells by targeting mitosis JO - Cell Death Differ VL - 19 UR - https://doi.org/10.1038/cdd.2011.197 DO - 10.1038/cdd.2011.197 ID - Manchado2012 ER - TY - JOUR AU - Chen-Zion, M. AU - Lilling, G. AU - Beitner, R. PY - 1993 DA - 1993// TI - The dual effects of Ca2 + on binding of the glycolytic enzymes, phosphofructokinase and aldolase, to muscle cytoskeleton JO - Biochem Med Metab Biol VL - 49 UR - https://doi.org/10.1006/bmmb.1993.1020 DO - 10.1006/bmmb.1993.1020 ID - Chen-Zion1993 ER - TY - JOUR AU - Hu, H. AU - Juvekar, A. AU - Lyssiotis, C. A. AU - Lien, E. C. AU - Albeck, J. G. AU - Oh, D. PY - 2016 DA - 2016// TI - Phosphoinositide 3-kinase regulates glycolysis through mobilization of aldolase from the actin cytoskeleton JO - Cell VL - 164 UR - https://doi.org/10.1016/j.cell.2015.12.042 DO - 10.1016/j.cell.2015.12.042 ID - Hu2016 ER - TY - JOUR AU - Mukai, T. AU - Joh, K. AU - Arai, Y. AU - Yatsuki, H. AU - Hori, K. PY - 1986 DA - 1986// TI - Tissue-specific expression of rat aldolase A mRNAs. Three molecular species differing only in the 5′-terminal sequences JO - J Biol Chem VL - 261 ID - Mukai1986 ER - TY - JOUR AU - Ji, S. AU - Zhang, B. AU - Liu, J. AU - Qin, Y. AU - Liang, C. AU - Shi, S. PY - 2016 DA - 2016// TI - ALDOA functions as an oncogene in the highly metastatic pancreatic cancer JO - Cancer Lett VL - 374 UR - https://doi.org/10.1016/j.canlet.2016.01.054 DO - 10.1016/j.canlet.2016.01.054 ID - Ji2016 ER - TY - JOUR AU - Shimizu, T. AU - Inoue, K. AU - Hachiya, H. AU - Shibuya, N. AU - Shimoda, M. AU - Kubota, K. PY - 2014 DA - 2014// TI - Frequent alteration of the protein synthesis of enzymes for glucose metabolism in hepatocellular carcinomas JO - J Gastroenterol VL - 49 UR - https://doi.org/10.1007/s00535-013-0895-x DO - 10.1007/s00535-013-0895-x ID - Shimizu2014 ER - TY - JOUR AU - Kawai, K. AU - Uemura, M. AU - Munakata, K. AU - Takahashi, H. AU - Haraguchi, N. AU - Nishimura, J. PY - 2017 DA - 2017// TI - Fructose-bisphosphate aldolase A is a key regulator of hypoxic adaptation in colorectal cancer cells and involved in treatment resistance and poor prognosis JO - Int J Oncol VL - 50 UR - https://doi.org/10.3892/ijo.2016.3814 DO - 10.3892/ijo.2016.3814 ID - Kawai2017 ER - TY - JOUR AU - Du, S. AU - Guan, Z. AU - Hao, L. AU - Song, Y. AU - Wang, L. AU - Gong, L. PY - 2014 DA - 2014// TI - Fructose-bisphosphate aldolase a is a potential metastasis-associated marker of lung squamous cell carcinoma and promotes lung cell tumorigenesis and migration JO - PLoS ONE VL - 9 UR - https://doi.org/10.1371/journal.pone.0085804 DO - 10.1371/journal.pone.0085804 ID - Du2014 ER - TY - JOUR AU - Chang, Y. C. AU - Chan, Y. C. AU - Chang, W. M. AU - Lin, Y. F. AU - Yang, C. J. AU - Su, C. Y. PY - 2017 DA - 2017// TI - Feedback regulation of ALDOA activates the HIF-1 alpha/MMP9 axis to promote lung cancer progression JO - Cancer Lett VL - 403 UR - https://doi.org/10.1016/j.canlet.2017.06.001 DO - 10.1016/j.canlet.2017.06.001 ID - Chang2017 ER - TY - JOUR AU - Sasaki, K. AU - Murakami, T. AU - Kawasaki, M. AU - Takahashi, M. PY - 1987 DA - 1987// TI - The cell cycle associated change of the Ki-67 reactive nuclear antigen expression JO - J Cell Physiol VL - 133 UR - https://doi.org/10.1002/jcp.1041330321 DO - 10.1002/jcp.1041330321 ID - Sasaki1987 ER - TY - JOUR AU - Urruticoechea, A. AU - Smith, I. E. AU - Dowsett, M. PY - 2005 DA - 2005// TI - Proliferation marker Ki-67 in early breast cancer JO - J Clin Oncol VL - 23 UR - https://doi.org/10.1200/JCO.2005.07.501 DO - 10.1200/JCO.2005.07.501 ID - Urruticoechea2005 ER - TY - JOUR AU - Warth, A. AU - Cortis, J. AU - Soltermann, A. AU - Meister, M. AU - Budczies, J. AU - Stenzinger, A. PY - 2014 DA - 2014// TI - Tumour cell proliferation (Ki-67) in non-small cell lung cancer: a critical reappraisal of its prognostic role JO - Br J Cancer VL - 111 UR - https://doi.org/10.1038/bjc.2014.402 DO - 10.1038/bjc.2014.402 ID - Warth2014 ER - TY - JOUR AU - Vasquez, R. J. AU - Howell, B. AU - Yvon, A. M. AU - Wadsworth, P. AU - Cassimeris, L. PY - 1997 DA - 1997// TI - Nanomolar concentrations of nocodazole alter microtubule dynamic instability in vivo and in vitro JO - Mol Biol Cell VL - 8 UR - https://doi.org/10.1091/mbc.8.6.973 DO - 10.1091/mbc.8.6.973 ID - Vasquez1997 ER - TY - JOUR AU - Kastan, M. B. AU - Bartek, J. PY - 2004 DA - 2004// TI - Cell-cycle checkpoints and cancer JO - Nature VL - 432 UR - https://doi.org/10.1038/nature03097 DO - 10.1038/nature03097 ID - Kastan2004 ER - TY - JOUR AU - Knudsen, E. S. AU - Knudsen, K. E. PY - 2008 DA - 2008// TI - Tailoring to RB: tumour suppressor status and therapeutic response JO - Nat Rev Cancer VL - 8 UR - https://doi.org/10.1038/nrc2401 DO - 10.1038/nrc2401 ID - Knudsen2008 ER - TY - JOUR AU - Burkhart, D. L. AU - Sage, J. PY - 2008 DA - 2008// TI - Cellular mechanisms of tumour suppression by the retinoblastoma gene JO - Nat Rev Cancer VL - 8 UR - https://doi.org/10.1038/nrc2399 DO - 10.1038/nrc2399 ID - Burkhart2008 ER - TY - JOUR AU - Choi, Y. J. AU - Li, X. AU - Hydbring, P. AU - Sanda, T. AU - Stefano, J. AU - Christie, A. L. PY - 2012 DA - 2012// TI - The requirement for cyclin D function in tumor maintenance JO - Cancer Cell VL - 22 UR - https://doi.org/10.1016/j.ccr.2012.09.015 DO - 10.1016/j.ccr.2012.09.015 ID - Choi2012 ER - TY - JOUR AU - Zhang, L. Q. AU - Jiang, F. AU - Xu, L. AU - Wang, J. AU - Bai, J. L. AU - Yin, R. PY - 2012 DA - 2012// TI - The role of cyclin D1 expression and patient’s survival in non-small-cell lung cancer: a systematic review with meta-analysis JO - Clin Lung Cancer VL - 13 UR - https://doi.org/10.1016/j.cllc.2011.10.003 DO - 10.1016/j.cllc.2011.10.003 ID - Zhang2012 ER - TY - JOUR AU - Massague, J. PY - 2004 DA - 2004// TI - G1 cell-cycle control and cancer JO - Nature VL - 432 UR - https://doi.org/10.1038/nature03094 DO - 10.1038/nature03094 ID - Massague2004 ER - TY - JOUR AU - Sobell, H. M. PY - 1985 DA - 1985// TI - Actinomycin and DNA transcription JO - Proc Natl Acad Sci USA VL - 82 UR - https://doi.org/10.1073/pnas.82.16.5328 DO - 10.1073/pnas.82.16.5328 ID - Sobell1985 ER - TY - JOUR AU - Klein, E. A. AU - Assoian, R. K. PY - 2008 DA - 2008// TI - Transcriptional regulation of the cyclin D1 gene at a glance JO - J Cell Sci VL - 121 UR - https://doi.org/10.1242/jcs.039131 DO - 10.1242/jcs.039131 ID - Klein2008 ER - TY - JOUR AU - Dhillon, A. S. AU - Hagan, S. AU - Rath, O. AU - Kolch, W. PY - 2007 DA - 2007// TI - MAP kinase signalling pathways in cancer JO - Oncogene VL - 26 UR - https://doi.org/10.1038/sj.onc.1210421 DO - 10.1038/sj.onc.1210421 ID - Dhillon2007 ER - TY - JOUR AU - Juergens, R. A. AU - Bratman, S. V. AU - Tsao, M. S. AU - Laurie, S. A. AU - Sara Kuruvilla, M. AU - Razak, A. R. PY - 2017 DA - 2017// TI - Biology and patterns of response to EGFR-inhibition in squamous cell cancers of the lung and head & neck JO - Cancer Treat Rev VL - 54 UR - https://doi.org/10.1016/j.ctrv.2017.01.003 DO - 10.1016/j.ctrv.2017.01.003 ID - Juergens2017 ER - TY - JOUR AU - Johnson, G. L. AU - Lapadat, R. PY - 2002 DA - 2002// TI - Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases JO - Science VL - 298 UR - https://doi.org/10.1126/science.1072682 DO - 10.1126/science.1072682 ID - Johnson2002 ER - TY - JOUR AU - Warburg, O. PY - 1925 DA - 1925// TI - The metabolism of carcinoma cells JO - J Cancer Res VL - 9 UR - https://doi.org/10.1158/jcr.1925.148 DO - 10.1158/jcr.1925.148 ID - Warburg1925 ER - TY - JOUR AU - Warburg, O. PY - 1956 DA - 1956// TI - On the origin of cancer cells JO - Science VL - 123 UR - https://doi.org/10.1126/science.123.3191.309 DO - 10.1126/science.123.3191.309 ID - Warburg1956 ER - TY - JOUR AU - Hanahan, D. AU - Weinberg, R. A. PY - 2011 DA - 2011// TI - Hallmarks of cancer: the next generation JO - Cell VL - 144 UR - https://doi.org/10.1016/j.cell.2011.02.013 DO - 10.1016/j.cell.2011.02.013 ID - Hanahan2011 ER - TY - JOUR AU - Vander Heiden, M. G. AU - Cantley, L. C. AU - Thompson, C. B. PY - 2009 DA - 2009// TI - Understanding the Warburg effect: the metabolic requirements of cell proliferation JO - Science VL - 324 UR - https://doi.org/10.1126/science.1160809 DO - 10.1126/science.1160809 ID - Vander Heiden2009 ER - TY - JOUR AU - Lunt, S. Y. AU - Vander Heiden, M. G. PY - 2011 DA - 2011// TI - Aerobic glycolysis: meeting the metabolic requirements of cell proliferation JO - Annu Rev Cell Dev Biol VL - 27 UR - https://doi.org/10.1146/annurev-cellbio-092910-154237 DO - 10.1146/annurev-cellbio-092910-154237 ID - Lunt2011 ER - TY - JOUR AU - Boroughs, L. K. AU - DeBerardinis, R. J. PY - 2015 DA - 2015// TI - Metabolic pathways promoting cancer cell survival and growth JO - Nat Cell Biol VL - 17 UR - https://doi.org/10.1038/ncb3124 DO - 10.1038/ncb3124 ID - Boroughs2015 ER - TY - JOUR AU - Luo, W. AU - Semenza, G. L. PY - 2012 DA - 2012// TI - Emerging roles of PKM2 in cell metabolism and cancer progression JO - Trends Endocrinol Metab VL - 23 UR - https://doi.org/10.1016/j.tem.2012.06.010 DO - 10.1016/j.tem.2012.06.010 ID - Luo2012 ER - TY - JOUR AU - Sun, H. AU - Zhu, A. AU - Zhang, L. AU - Zhang, J. AU - Zhong, Z. AU - Wang, F. PY - 2015 DA - 2015// TI - Knockdown of PKM2 suppresses tumor growth and invasion in lung adenocarcinoma JO - Int J Mol Sci VL - 16 UR - https://doi.org/10.3390/ijms161024574 DO - 10.3390/ijms161024574 ID - Sun2015 ER - TY - JOUR AU - Yang, W. AU - Xia, Y. AU - Ji, H. AU - Zheng, Y. AU - Liang, J. AU - Huang, W. PY - 2011 DA - 2011// TI - Nuclear PKM2 regulates beta-catenin transactivation upon EGFR activation JO - Nature VL - 480 UR - https://doi.org/10.1038/nature10598 DO - 10.1038/nature10598 ID - Yang2011 ER - TY - JOUR AU - Yang, W. AU - Xia, Y. AU - Hawke, D. AU - Li, X. AU - Liang, J. AU - Xing, D. PY - 2012 DA - 2012// TI - PKM2 phosphorylates histone H3 and promotes gene transcription and tumorigenesis JO - Cell VL - 150 UR - https://doi.org/10.1016/j.cell.2012.07.018 DO - 10.1016/j.cell.2012.07.018 ID - Yang2012 ER - TY - JOUR AU - Wao, H. AU - Mhaskar, R. AU - Kumar, A. AU - Miladinovic, B. AU - Djulbegovic, B. PY - 2013 DA - 2013// TI - Survival of patients with non-small cell lung cancer without treatment: a systematic review and meta-analysis JO - Syst Rev VL - 2 UR - https://doi.org/10.1186/2046-4053-2-10 DO - 10.1186/2046-4053-2-10 ID - Wao2013 ER - TY - JOUR AU - Zhang, F. AU - Lin, J. D. AU - Zuo, X. Y. AU - Zhuang, Y. X. AU - Hong, C. Q. AU - Zhang, G. J. PY - 2017 DA - 2017// TI - Elevated transcriptional levels of aldolase A (ALDOA) associates with cell cycle-related genes in patients with NSCLC and several solid tumors JO - BioData Min VL - 10 UR - https://doi.org/10.1186/s13040-016-0122-4 DO - 10.1186/s13040-016-0122-4 ID - Zhang2017 ER - TY - JOUR AU - Ritterson Lew, C. AU - Tolan, D. R. PY - 2012 DA - 2012// TI - Targeting of several glycolytic enzymes using RNA interference reveals aldolase affects cancer cell proliferation through a non-glycolytic mechanism JO - J Biol Chem VL - 287 UR - https://doi.org/10.1074/jbc.M112.405969 DO - 10.1074/jbc.M112.405969 ID - Ritterson Lew2012 ER - TY - JOUR AU - Mamczur, P. AU - Gamian, A. AU - Kolodziej, J. AU - Dziegiel, P. AU - Rakus, D. PY - 2013 DA - 2013// TI - Nuclear localization of aldolase A correlates with cell proliferation JO - Biochim Biophys Acta VL - 1833 UR - https://doi.org/10.1016/j.bbamcr.2013.07.013 DO - 10.1016/j.bbamcr.2013.07.013 ID - Mamczur2013 ER - TY - JOUR AU - Ma, D. AU - Chen, X. AU - Zhang, P. Y. AU - Zhang, H. AU - Wei, L. J. AU - Hu, S. PY - 2018 DA - 2018// TI - Upregulation of the ALDOA/DNA-PK/p53 pathway by dietary restriction suppresses tumor growth JO - Oncogene VL - 37 UR - https://doi.org/10.1038/onc.2017.398 DO - 10.1038/onc.2017.398 ID - Ma2018 ER - TY - JOUR AU - Hirsch, F. R. AU - Varella-Garcia, M. AU - Bunn, P. A. AU - Maria, M. V. AU - Veve, R. AU - Bremnes, R. M. PY - 2003 DA - 2003// TI - Epidermal growth factor receptor in non-small-cell lung carcinomas: correlation between gene copy number and protein expression and impact on prognosis JO - J Clin Oncol VL - 21 UR - https://doi.org/10.1200/JCO.2003.11.069 DO - 10.1200/JCO.2003.11.069 ID - Hirsch2003 ER - TY - JOUR AU - Normanno, N. AU - Luca, A. AU - Bianco, C. AU - Strizzi, L. AU - Mancino, M. AU - Maiello, M. R. PY - 2006 DA - 2006// TI - Epidermal growth factor receptor (EGFR) signaling in cancer JO - Gene VL - 366 UR - https://doi.org/10.1016/j.gene.2005.10.018 DO - 10.1016/j.gene.2005.10.018 ID - Normanno2006 ER - TY - JOUR AU - Laurie, S. A. AU - Goss, G. D. PY - 2013 DA - 2013// TI - Role of epidermal growth factor receptor inhibitors in epidermal growth factor receptor wild-type non-small-cell lung cancer JO - J Clin Oncol VL - 31 UR - https://doi.org/10.1200/JCO.2012.43.4522 DO - 10.1200/JCO.2012.43.4522 ID - Laurie2013 ER - TY - JOUR AU - Lynch, T. J. AU - Bell, D. W. AU - Sordella, R. AU - Gurubhagavatula, S. AU - Okimoto, R. A. AU - Brannigan, B. W. PY - 2004 DA - 2004// TI - Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib JO - N Engl J Med VL - 350 UR - https://doi.org/10.1056/NEJMoa040938 DO - 10.1056/NEJMoa040938 ID - Lynch2004 ER - TY - JOUR AU - Paez, J. G. AU - Janne, P. A. AU - Lee, J. C. AU - Tracy, S. AU - Greulich, H. AU - Gabriel, S. PY - 2004 DA - 2004// TI - EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy JO - Science VL - 304 UR - https://doi.org/10.1126/science.1099314 DO - 10.1126/science.1099314 ID - Paez2004 ER - TY - JOUR AU - Miller, V. A. AU - Hirsh, V. AU - Cadranel, J. AU - Chen, Y. M. AU - Park, K. AU - Kim, S. W. PY - 2012 DA - 2012// TI - Afatinib versus placebo for patients with advanced, metastatic non-small-cell lung cancer after failure of erlotinib, gefitinib, or both, and one or two lines of chemotherapy (LUX-Lung 1): a phase 2b/3 randomised trial JO - Lancet Oncol VL - 13 UR - https://doi.org/10.1016/S1470-2045(12)70087-6 DO - 10.1016/S1470-2045(12)70087-6 ID - Miller2012 ER - TY - JOUR AU - Kobayashi, S. AU - Boggon, T. J. AU - Dayaram, T. AU - Janne, P. A. AU - Kocher, O. AU - Meyerson, M. PY - 2005 DA - 2005// TI - EGFR mutation and resistance of non-small-cell lung cancer to gefitinib JO - N Engl J Med VL - 352 UR - https://doi.org/10.1056/NEJMoa044238 DO - 10.1056/NEJMoa044238 ID - Kobayashi2005 ER - TY - JOUR AU - Maemondo, M. AU - Inoue, A. AU - Kobayashi, K. AU - Sugawara, S. AU - Oizumi, S. AU - Isobe, H. PY - 2010 DA - 2010// TI - Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR JO - N Engl J Med VL - 362 UR - https://doi.org/10.1056/NEJMoa0909530 DO - 10.1056/NEJMoa0909530 ID - Maemondo2010 ER - TY - JOUR AU - Pirker, R. AU - Pereira, J. R. AU - Szczesna, A. AU - Pawel, J. AU - Krzakowski, M. AU - Ramlau, R. PY - 2009 DA - 2009// TI - Cetuximab plus chemotherapy in patients with advanced non-small-cell lung cancer (FLEX): an open-label randomised phase III trial JO - Lancet VL - 373 UR - https://doi.org/10.1016/S0140-6736(09)60569-9 DO - 10.1016/S0140-6736(09)60569-9 ID - Pirker2009 ER - TY - JOUR AU - Hanna, N. AU - Lilenbaum, R. AU - Ansari, R. AU - Lynch, T. AU - Govindan, R. AU - Janne, P. A. PY - 2006 DA - 2006// TI - Phase II trial of cetuximab in patients with previously treated non-small-cell lung cancer JO - J Clin Oncol VL - 24 UR - https://doi.org/10.1200/JCO.2006.08.2263 DO - 10.1200/JCO.2006.08.2263 ID - Hanna2006 ER - TY - JOUR AU - Gomes, J. R. AU - Cruz, M. R. S. PY - 2015 DA - 2015// TI - Combination of afatinib with cetuximab in patients with EGFR-mutant non-small-cell lung cancer resistant to EGFR inhibitors JO - Oncotargets Ther VL - 8 UR - https://doi.org/10.2147/OTT.S75388 DO - 10.2147/OTT.S75388 ID - Gomes2015 ER - TY - JOUR AU - Nukaga, S. AU - Yasuda, H. AU - Tsuchihara, K. AU - Hamamoto, J. AU - Masuzawa, K. AU - Kawada, I. PY - 2017 DA - 2017// TI - Amplification of EGFR wild-type alleles in non-small cell lung cancer cells confers acquired resistance to mutation-selective EGFR tyrosine kinase inhibitors JO - Cancer Res VL - 77 UR - https://doi.org/10.1158/0008-5472.CAN-16-2359 DO - 10.1158/0008-5472.CAN-16-2359 ID - Nukaga2017 ER - TY - JOUR AU - Estrella, V. AU - Chen, T. AU - Lloyd, M. AU - Wojtkowiak, J. AU - Cornnell, H. H. AU - Ibrahim-Hashim, A. PY - 2013 DA - 2013// TI - Acidity generated by the tumor microenvironment drives local invasion JO - Cancer Res VL - 73 UR - https://doi.org/10.1158/0008-5472.CAN-12-2796 DO - 10.1158/0008-5472.CAN-12-2796 ID - Estrella2013 ER - TY - JOUR AU - Colegio, O. R. AU - Chu, N. Q. AU - Szabo, A. L. AU - Chu, T. AU - Rhebergen, A. M. AU - Jairam, V. PY - 2014 DA - 2014// TI - Functional polarization of tumour-associated macrophages by tumour-derived lactic acid JO - Nature VL - 513 UR - https://doi.org/10.1038/nature13490 DO - 10.1038/nature13490 ID - Colegio2014 ER - TY - JOUR AU - Locasale, J. W. AU - Cantley, L. C. PY - 2011 DA - 2011// TI - Metabolic flux and the regulation of mammalian cell growth JO - Cell Metab VL - 14 UR - https://doi.org/10.1016/j.cmet.2011.07.014 DO - 10.1016/j.cmet.2011.07.014 ID - Locasale2011 ER - TY - JOUR AU - Lim, S. AU - Liu, H. AU - Madeira da Silva, L. AU - Arora, R. AU - Liu, Z. AU - Phillips, J. B. PY - 2016 DA - 2016// TI - Immunoregulatory protein B7-H3 reprograms glucose metabolism in cancer cells by ROS-mediated stabilization of HIF1alpha JO - Cancer Res VL - 76 UR - https://doi.org/10.1158/0008-5472.CAN-15-1538 DO - 10.1158/0008-5472.CAN-15-1538 ID - Lim2016 ER - TY - JOUR AU - Lu, C. AU - Thompson, C. B. PY - 2012 DA - 2012// TI - Metabolic regulation of epigenetics JO - Cell Metab VL - 16 UR - https://doi.org/10.1016/j.cmet.2012.06.001 DO - 10.1016/j.cmet.2012.06.001 ID - Lu2012 ER - TY - JOUR AU - Liu, X. S. AU - Little, J. B. AU - Yuan, Z. M. PY - 2015 DA - 2015// TI - Glycolytic metabolism influences global chromatin structure JO - Oncotarget VL - 6 ID - Liu2015 ER - TY - JOUR AU - Kong, X. J. AU - Kuilman, T. AU - Shahrabi, A. AU - Oshuizen, J. B. AU - Kemper, K. AU - Song, J. Y. PY - 2017 DA - 2017// TI - Cancer drug addiction is relayed by an ERK2-dependent phenotype switch JO - Nature VL - 550 UR - https://doi.org/10.1038/nature24037 DO - 10.1038/nature24037 ID - Kong2017 ER -